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Abstract 20 
Hydroxytyrosol (HT), a virgin olive oil phenolic phytochemical with proven health benefits, 21 
has been used to generate new lipophilic antioxidants to preserve fats and oils against 22 
autoxidation. The aim of this work is to comparatively evaluate the physiological effects of 23 
HT and the lipophilic derivatives, hydroxytyrosyl acetate (HT-Ac) and ethyl hydroxytyrosyl 24 
ether (HT-Et) in a high-cholesterol fed animals. Male Wistar rats (n=8) were fed a standard 25 
diet (C group), a cholesterol-rich diet (Chol group) or cholesterol-rich diets supplemented 26 
with the phenolic compounds (HT group, HT-Ac group and HT-Et group) for 8 weeks. Body 27 
and tissue weights, lipid profile, redox status, and biochemical, hormonal, and inflammatory 28 
biomarkers were evaluated. Plasma levels of total, LDL-cholesterol, glucose, insulin and 29 
leptin, as well as malondialdehyde in serum increased in Chol compared to C (p<0.05). Rats 30 
fed the test diets improved their glucose, insulin, leptin and MDA levels and antioxidant 31 
capacity status, being HT-Ac the most effective compound. The studied phenolic compounds 32 
also modulated TNF-α and IL-1β plasma levels compared to Chol. HT-Ac and HT-Et 33 
improved adipose tissue distribution and adipokine production, decreasing MCP-1 and IL-1β 34 
levels. Our results confirm the metabolic effects of HT, which are maintained and even 35 
improved by the hydrophobic derivatives, particularly in HT-Ac. 36 
 37 
Keywords: Ethyl hydroxytyrosyl ether; hydroxytyrosol; hydroxytyrosyl acetate; 38 
hypercholesterolemic rats; metabolic stress.  39 
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1. Introduction  41 
The most representative phenolic compound in virgin olive oil, hydroxytyrosol 42 
(HT), plays and important role in the prevention of degenerative diseases
1-2
. Explicitly, it 43 
is involved in the reduction of LDL oxidation, a well-known cardiovascular risk factor
3
, 44 
and it is transiently associates with LDL lipoproteins
4
. Moreover, HT is involved in the 45 
inhibition of lipid and protein oxidation in human plasma 
5
, having anti-inflammatory
6
 46 
and antiplatelet aggregation activities
7
. Additionally, there is evidence that olive oil 47 
phenolic compounds decrease plasma glucose levels in rats
8-9
. HT can be efficiently 48 
recovered from olive by-products, which has prompted the study of the biological and 49 
health effects of HT from alperujo
8, 10
 or olive leaves.
9, 11
 50 
On the other hand, the food industry demands new lipophilic antioxidants to 51 
preserve fats and oils against autoxidation. Two series of hydrophobic derivatives of HT, 52 
hydroxytyrosyl esters
12 
and hydroxytyrosyl ethers
13
, have been synthesized. 53 
Hydroxytyrosyl acetate (HT-Ac) merits special interest among hydroxytyrosyl esters, 54 
since it is an antioxidant naturally present in virgin olive oil
14
 that is transported across 55 
the small intestinal epithelial cell barrier more efficiently than HT,
15 
showing a higher 56 
hepatic bioavailability than HT
16
. Moreover, HT-Ac has shown protective effects against 57 
oxidative DNA damage in blood cells
17
, iron-induced oxidative stress in human cervical 58 
cells,
18
 and oxidative stress in HepG2 cells
19
. Hydroxytyrosyl ethyl ether (HT-Et), with an 59 
alkyl chain with the same length as the acyl chain in HT-Ac, was included in this study to 60 
assess the influence of the different functional groups (etherification versus esterification) 61 
on the biological activity of the two phenolic compounds. HT-Et is absorbed to a higher 62 
extent in Caco-2 cells than its precursor HT,
20 
with absorption rate similar to that of HT-63 
Ac,
15
 being also broadly taken-up by HepG2 cells
21
. In addition, HT-Et protects hepatic 64 
human HepG2 cells against oxidative stress
22
 and inhibits platelet activation after oral 65 
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administration in rats
23
.These antecedents justify using this compound although it is not 66 
naturally present in virgin olive oil. 67 
Both HT-Ac and HT-Et maintain the orthodiphenolic group intact and show 68 
higher antioxidant capacity than HT
24-25
, preserving their potential application as 69 
antioxidants to stabilize foodstuffs or as functional food ingredients.  70 
With these antecedents, the aim of the present study was to comparatively 71 
analyse the ability of HT and its lipophilic derivatives, HT-Ac and HT-Et, counteracting 72 
the metabolic deregulation derived from consuming a high-cholesterol diet, focusing on 73 
the effects on plasma lipids, glucose levels, hormone response, oxidative stress and pro-74 
inflammatory status. In addition, body weight gain, adipose tissue distribution and 75 
secretion of adipokines from visceral fat were evaluated.  76 
 77 
2. Experimental 78 
2.1. Materials and Chemical 79 
Cholesterol, cholic acid, palmitic acid, 6-hydroxy-2,5,7,8-tetramethylchroman-2-80 
carboxilic acid (Trolox), 1,1,3,3-tetraethoxypropane, fluorescein, 2,2’-azobis(2-81 
amidinopropane) dihydrochloride (AAPH), trizmabase, dithiothreitol, 1,1,3,3-82 
tetraethoxypropane and 2,4-dinitrophenylhydrazine were purchased from Sigma-Aldrich 83 
Chemical (Madrid, Spain). Sodium hydroxide, sulphuric acid, sodium hydrogen phosphate 84 
and potassium dihydrogen phosphate were from Panreac (Madrid, Spain). The Bradford 85 
reagent was from BioRad (BioRad Laboratories S.A., Madrid, Spain). Free fatty acids (FFA) 86 
colorimetric kit was purchased from Roche (Roche Applied Science, Madrid Spain). Rat 87 
adipocyte (RADPCYT-82K, MilliplexMap Rat Adipocyte Panel) and adipokine (RADPK-88 
81K, MilliplexMap Kit Rat Serum Adipokine Panel) Milliplex kits were acquired from 89 
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Millipore (Millipore, Billerica, MA, US, USA). Other reagents were of analytical or 90 
chromatographic quality. 91 
HT was isolated with 98% purity from olive oil waste water following a patented 92 
procedure 
26 
and further purified by column chromatography. 93 
HT-Ac was obtained from HT in ethyl acetate after incubation with p-94 
toluenesulfonic acid and purification by column chromatography following a patented 95 
procedure 
12
.  96 
HT-Et was obtained from HT by chemical synthesis as described elsewhere
13
. 97 
 98 
2.2. Diet, animals and experimental design 99 
Forty male Wistar rats (200–225 g body weight) were purchased from an accredited 100 
supplier (Charles River Laboratorios España, S.A. Barcelona, Spain) and housed in 101 
metabolic cages. They had free access to food and water, and were maintained under a 102 
normal light–dark cycle in the Experimental Surgery Service of La Paz University Hospital 103 
(registration number: 280790001941). After one week of acclimation, animals were 104 
randomly distributed into 5 different experimental groups (8 rats per group). One group 105 
received the standard, maintenance rodent diet (A04-SAFE, Augy, France), which is the 106 
control (C group), and four groups were fed the standard diet supplemented with 2% 107 
cholesterol and 0.4% cholic acid in order to generate the hypercholesterolemic model as 108 
described elsewhere 
27
. In three of these groups the hypercholesterolemic diet was 109 
supplemented with 0.04% of HT (HT group), HT-Ac (HT-Ac group) and HT-Et (HT-Et 110 
group), respectively, to assess the potential beneficial effects of these phenolic compounds in 111 
the hypercholesterolemic rat model. Nutritional and energetic content of each diet is 112 
summarized in Table 1. During the whole intervention, animal health status and dietary 113 
tolerance were monitored by veterinary individual observation in addition to weekly control 114 
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of animals’ weight (Table 2). After 8 weeks animals were subjected to complete 115 
exsanguination under general anesthesia (isoflurane 2%). Plasma and serum fractions were 116 
separated by centrifugation (10 minutes at 2500 g) using pretreated EDTA or Silica Act Cot 117 
Activator blood collection tubes (BD Vacutainer, Plymouth, UK) respectively, and stored at -118 
20ºC until further analysis. Liver, kidney, heart and adipose tissue from retroperitoneal and 119 
epididymal areas were collected, weighed and washed in ice-cold phosphate buffered saline. 120 
Samples were immediately frozen in liquid nitrogen and stored at -80ºC until analysis. The 121 
study protocol was approved by the Institutional Animal Ethics Committee of La Paz 122 
University Hospital (Madrid, Spain) and procedures were performed in accordance with 123 
Spanish law for the protection of experimental animals and other research purposes (RD 124 
53/2013, BOE nº 34 Sec I pg 11370 8
th
 February 2013). 125 
 126 
2.3. Blood biochemical analyses 127 
Triglycerides, total cholesterol, LDL-cholesterol, HDL-cholesterol, glucose and 128 
creatinine in plasma were determined using an automated analyser (Beckman Coulter-Former 129 
Olympus Diagnostics AU 5420, Nyon, Switzerland). Plasma free fatty acids (FFA) 130 
concentration was determined with a colorimetric commercial assay kit (Free Fatty Acids, 131 
Half Micro Test, Roche Applied Science) using palmitic acid as standard.  132 
 133 
2.4. Determination of oxygen radical scavenging capacity (ORAC) in serum. 134 
Serum antioxidant activity was analysed using the hydrophilic oxygen radical 135 
scavenging capacity (ORAC) assay according to the method developed by Huang, Ou, 136 
Hampsch-Woodill, Flanagan& Prior
28
. The fluorescence at 485 and 528nm excitation and 137 
emission wavelengths, respectively, was determined in a 96 well microplate reader (Bio-Tek, 138 
Winooski, VT, USA). ORAC values were expressed as micromoles of Trolox / mL serum. 139 
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 140 
2.5. Determination of Malondialdehyde (MDA) in serum and liver.  141 
MDA was determined as its hydrazone by high-performance liquid chromatography 142 
using 2,4-dinitrophenylhydrazine for derivatization
29
. Livers (0.5g) were homogenized (1:5 143 
w/v) in ice-cold 0.25M Trizma base buffer pH 7.4 containing 5mM dithiothreitol using an 144 
Ultra Turrax (IKA® Works Inc., WilmingtonNC) at 18000 rpm. After centrifugation 145 
(11000rpm 30min, 4ºC), supernatants were collected for MDA quantification. Serum samples 146 
were analysed directly. Standard MDA was prepared by acidic hydrolysis of 1,1,3,3-147 
tetraethoxypropane in 1% sulphuric acid. Concentrations were expressed as nanomoles of 148 
MDA per milligram of protein in liver tissue and per millilitre in serum. Protein content in 149 
liver homogenates was estimated by the Bradford method using a Bio-Rad protein assay kit. 150 
 151 
2.6. Determination of cytokines and hormones in plasma and adipose tissue by 152 
immunoassay. 153 
A sample of white adipose tissue from the retroperitoneal area (0.2g) was collected 154 
and homogenized (1:3.5 w/v) in PBS (pH 7.4) with Triton X-100 and protease inhibitor by 155 
low temperature sonication (17 microns, 3 consecutive pulses of 15 seconds at 30 seconds 156 
intervals). After centrifugation (5000rpm, 10min, 4ºC), the lipid layer was removed and 157 
supernatants were collected for adipokine determination. The concentration of leptin, 158 
interleukin-1β (IL-1β), interleukin-6 (IL-6), tumour necrosis factor-α (TNF-α), monocyte 159 
chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in the 160 
retroperitoneal adipose tissue were determined using a Rat Adipocyte Multiplex Kits 161 
(RADPCYT-82K Milliplex Map Kit, Rat Adipocyte Panel, Millipore, Billerica, MA, US). 162 
IL-1β, IL-6, TNF-α, insulin and leptin concentrations were determined in plasma samples 163 
obtained at the end of the intervention using a Rat Adipokine multiplex kits (RADPK-81K, 164 
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Milliplex Map Kit, Rat Serum Adipokine Panel, Millipore, Billerica, MA, US). Multianalyte 165 
profiling panels were used according to manufacturer’s instructions and analysed on a 166 
LuminexLX200 Analyzer. Data were analysed using the 3.1 xPONENT software (Millipore); 167 
high and low concentration quality controls were used with all the biomarkers. Protein 168 
content in adipose tissue homogenates was estimated by the Bradford method using a Bio-169 
Rad protein assay kit. 170 
 171 
2.7. Statistical analysis. 172 
All data were expressed as the mean ± standard deviation (SD). Non parametric 173 
significant test (Kruskal-Wallis one-way analysis of variance and Mann-Whitney U test) was 174 
performed to compare values. Differences were considered statistically significant when p < 175 
0.05 and in Mann-Whitney U test the significance was adjusted with a Bonferroni test. Data 176 
were analysed using the statistical package SPSSv.19.0 software (SPSS, Institute Inc, Cary, 177 
NC).  178 
 179 
3. Results 180 
3.1.Food intake, body weight gain and tissues weights 181 
All diets provided equivalent amounts of carbohydrates and proteins. However, 182 
cholesterol-rich diets led to an excess of lipids resulting in an 8.5 Kcal/100g higher caloric 183 
intake. During the 8-week study period, animals in the five experimental groups had similar 184 
daily food intakes (approximately 20g/d). 185 
Therefore, the groups consuming the cholesterol-rich diets (Chol, HT, HT-Ac and 186 
HT-Et) presented a daily caloric excess of approximately 2 Kcal/day. However, this did not 187 
induce significant differences in the body weight gain compared with the control animals, as 188 
can be seen in Table 2. 189 
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Considering an average daily food intake of 20g and an average body weight of 190 
300g, the daily phenolic compound intake was 25mg/kg body weight/day. This is a relatively 191 
low dose, comparable with doses used in some other studies 
8-11
 and within a range proven to 192 
elicit no toxic effects in rats. Accordingly, no pathologic alterations or behaviours were 193 
observed in the animals during the study. Organs, including kidney or heart among others, 194 
presented normal appearance by gross observation. However, livers in animals fed the 195 
cholesterol-rich diets showed a whitish appearance compared with the C group, suggestive of 196 
fat accumulation, being significantly heavier than those of the C group (Table 2). Adipose 197 
tissue depots were obtained from retroperitoneal and epididymal areas, and when their 198 
weights were normalized for the final animal body weight, no differences were observed 199 
among different treatments. However, the ratio obtained with the adipose tissue from 200 
retroperitoneal area/epididymal area showed significant differences, being higher in the Chol 201 
and HT groups than in the C group. 202 
 203 
3.2. Plasma cholesterol profile  204 
As Figure 1 shows, animals fed the cholesterol-rich diets had a marked 205 
hyperlipidaemia, with high LDL-cholesterol and total cholesterol concentrations, although 206 
HDL-cholesterol levels were not affected as compared to C group. Although not reaching the 207 
values of control animals, supplementation of the cholesterol-rich diet with 0.04% HT-Ac 208 
significantly decreased the total cholesterol and LDL-cholesterol levels as compared with the 209 
Chol group (p<0.05), which was not attained in the HT and HT-Et groups. 210 
 211 
3.3. Biochemical parameters and hormones involved in energy homeostasis 212 
The high-cholesterol diet used in the present study induced a significant increase in 213 
glucose levels in the Chol group compared to control animals (p<0.05). All the tested 214 
Page 9 of 28 Food & Function
 10 
phenolic compounds counteracted the glucose increase, with a partial effect of HT-Et 215 
whereas values in HT-Ac and HT groups returned to control levels (Table 3). 216 
Triglycerides concentrations were similar in all groups, although phenolic 217 
compounds supplementation induced a moderate yet non-significant decrease. No differences 218 
were observed in plasma concentrations of free fatty acids, whereas creatinine concentrations 219 
were statistically higher in Chol and HT groups, compared to C, HT-Ac and HT-Et groups 220 
(Table 3). 221 
After consuming the high-cholesterol diet for 8 weeks significant differences in 222 
plasma insulin and leptin concentrations were observed in Chol compared to C group. 223 
However, rats consuming diets supplemented with HT and HT-Ac had significantly lower 224 
plasma insulin levels than Chol, decreasing to control or even lower values as in the HT-Ac 225 
group (Table 3). HT-Et also presented lower insulin levels than Chol group although not 226 
statistically different (p=0.070), showing intermediate values between Chol and C groups.  227 
Leptin levels were lower in HT and HT-Et groups than in the Chol group, although not 228 
reaching values of control animals. Again, HT-Ac group had significantly lower plasma 229 
leptin levels than Chol group and in the range of the control values. In the retroperitoneal 230 
adipose tissue, leptin concentration was slightly lower in all cholesterol treated groups 231 
compared to the C animals, although not significantly different. 232 
 233 
3.4. Redox status and inflammatory biomarkers in blood and tissue samples 234 
Serum antioxidant activity (Table 4), analysed using the ORAC assay, was lower in 235 
Chol group compared to the control group without reaching the level of statistical 236 
significance. However, rats fed with HT and HT-Ac diets showed a significantly higher 237 
serum antioxidant activity compared with Chol group (p<0.05). 238 
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Regarding the biomarker of lipid peroxidation, Chol group showed MDA levels 239 
significantly higher than C animals in serum and liver (p<0.05). Supplementation with any of 240 
the studied phenolic compounds decreased MDA levels to control values in serum (Table 4). 241 
However, although the three phenolic compounds-supplemented groups showed lower 242 
hepatic MDA levels than Chol group, differences were statistically significant only in the 243 
HT-Et group (p<0.05) (Table 4). 244 
Consuming the cholesterol-rich diet significantly increased the pro-inflammatory 245 
cytokine TNFα plasma concentrations compared to C group, effect that was totally 246 
counteracted by the three phenolic compounds (Table 4). A similar response was observed 247 
with IL-1β, with increased values in the Chol group returning to control levels in the HT, HT-248 
Ac and HT-Et animals, although differences did not reach the level of statistical significance 249 
(Table 4). Plasma IL-6 was not affected by the cholesterol-rich diets or the phenolic 250 
supplementation. 251 
Cytokine concentrations in the visceral adipose tissue from retroperitoneal area of the 252 
rats in the Chol group were similar to those in C group. TNFα and IL-6 concentrations were 253 
unchanged in all the experimental groups; however, IL-1β concentrations were lower in HT-254 
Ac and HT-Et groups. Accordingly, MCP-1 showed significantly lower concentrations in 255 
HT-Ac and HT-Et groups compared to C group (Table 4). PAI-1 concentrations showed 256 
similar tendency, but differences did not reach statistical significance.  257 
 258 
4. Discussion 259 
In the present study the effects of HT were studied in comparison with HT-Ac and 260 
HT-Et, two lipophilic derivatives of HT with a higher intestinal bioavailability than their 261 
precursor
15, 20
. The evaluation of the biological properties of these three compounds was 262 
performed focusing on plasma lipids, energy homeostasis and oxidative and inflammatory 263 
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status in rats fed a cholesterol-rich diet. This study shows that HT and its hydrophobic 264 
derivatives induce beneficial metabolic effects in hypercholesterolemic rats. Particularly, 265 
HT-Ac showed the highest capacity to counteract the metabolic stress induced by the high-266 
cholesterol diet. 267 
Supplementation of the diets with a moderate amount of phenolic compounds 268 
(0.04%) resulted in a daily intake of 25mg/kg body weight, which is far beyond any possible 269 
toxic level considering a recently published a study where consumption of up to 500 270 
mg/kg/day was described as a No Observed Adverse Effects Level (NOAEL)
30
. 271 
As expected, feeding rats with a diet rich in cholesterol resulted in an increase in 272 
total cholesterol and LDL cholesterol levels. In this hypercholesterolemic model, HT and 273 
HT-Et showed modest plasma LDL-cholesterol lowering effects, in contrast to HT-Ac that 274 
significantly reduced total and LDL-cholesterol levels compared to Chol group. These results 275 
are in line with previous human and animal studies showing that phenolic compounds present 276 
in virgin olive oil exert beneficial cardiovascular effects, particularly improving lipid profile
8, 
277 
10, 31
. In fact, the European Food Safety Authority has recently issued a positive opinion on 278 
olive oil phenolic compounds capacity to protect LDL cholesterol from oxidative damage
32
.  279 
Several markers show that rats in the present study suffered hepatic stress induced 280 
by the cholesterol-rich diet, which may have led to an incipient insulin resistance
2
. 281 
Comparing the Chol and C groups, the high-cholesterol diet induced a significant increase in 282 
glucose, creatinine, insulin and leptin plasma concentrations. In addition, Chol 283 
hypercholesterolemic animals presented higher liver weights than C animals and the adipose 284 
depots were mainly distributed in the retroperitoneal area. Interestingly, the diets 285 
supplemented with phenolic compounds counteracted the glucose and insulin increase, 286 
particularly HT and HT-Ac. This outcome is in accordance with previous studies showing 287 
that HT and other olive oil phenolic compounds reduce plasma glucose concentration in 288 
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alloxan-diabetic rats
8-9 
by means of alleviating oxidative stress and free radicals as well as 289 
enhancing enzymatic defences. A recent paper evidenced the capacity of oleuropein aglycone 290 
in the prevention of cytotoxic amyloid aggregation of human amylin, a hallmark of Type-II 291 
diabetes
33
. In accordance, the PREDIMED study showed that consuming a virgin olive oil-292 
enriched traditional Mediterranean diet for three months decreased total and LDL cholesterol 293 
together with plasma glucose in asymptomatic high cardiovascular-risk patients, although no 294 
changes were observed in insulin levels
34
. In line with these results, a significant decrease of 295 
glycaemia related to a long term daily intake of a virgin olive oil rich in phenolic compounds 296 
was observed in healthy young subjects
35
. HT-Ac also maintained plasma leptin at 297 
concentrations similar to those in the C group, while this effect was more discrete in the case 298 
of HT and HT-Et. Similarly, in rats that consumed the diet supplemented with HT-Ac and 299 
HT-Et creatinine concentrations were restored to control levels, but not with HT. The renal 300 
protective effect of olive phenols reducing creatinine levels has already been described in 301 
diabetic rats
8
.  302 
The retroperitoneal/epididymal fat ratio provides information about adipose tissue 303 
distribution, being directly proportional to the abdominal fat accumulation. Both 304 
retroperitoneal and epididymal adipose depots are considered visceral fat associated with 305 
higher levels of inflammation and lipolysis than subcutaneous fat, having been related with 306 
insulin resistance
36
. The retroperitoneal adipose depots in rats could be related to abdominal 307 
adiposity in humans since they are located inside the peritoneum attached to the dorsal area 308 
of the abdomen, whereas epididymal adipose tissue would correspond to gonadal fat, which 309 
exists in mice and rats but not in humans. The groups supplemented with the lipophilic 310 
compounds (HT-Ac and HT-Et) moderately improved the retroperitoneal/epididymal fat ratio 311 
compared to Chol group, whereas the group that consumed HT did not show changes. Our 312 
results are in agreement with the reduction in abdominal fat deposition described in a 313 
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metabolic syndrome animal model that consumed a diet supplemented with an olive leaf 314 
extract rich in HT
37
.  315 
Metabolic disturbance which includes hyperlipidaemia, hyperglycaemia and 316 
hyperinsulinemia often involves chronic inflammation and oxidative stress
2, 8, 11
. Therefore, 317 
redox status and inflammatory biomarkers were analyzed in plasma in order to understand 318 
the potential mechanisms underlying the effects of the studied phenolic compounds. 319 
Although the possible health implications related to MDA changes remain unknown, in this 320 
study elevated systemic MDA concentrations were observed in the Chol group, suggesting a 321 
marked oxidative stress in these animals that was counteracted by the consumption of the 322 
phenolic compounds. Moreover, the serum antioxidant capacity of animals consuming the 323 
phenolic compounds was higher than in the Chol group, particularly HT and HT-Ac. 324 
However, at the hepatic level phenolic compounds supplementation did not decrease MDA 325 
levels to control values although hepatic peroxidation was reduced in all cases, especially in 326 
the HT-Et group (Table 4). It is noteworthy that the studied phenolic compounds follow 327 
different metabolic pathways when ingested.HT-Ac is extensively hydrolysed into free HT, 328 
whereas HT-Et remains unaltered, yielding more lipophilic metabolites than those generated 329 
after HT and HT-Ac hepatic metabolism
15, 20
. This would result in higher HT-Et 330 
bioaccumulation in hepatic tissue, conferring higher protection against oxidation than HT and 331 
HT-Ac metabolites. 332 
The protective role of olive oil phenolic compounds against oxidative damage is 333 
well established and has been reviewed recently
1
. The antioxidant and free radical 334 
scavenging capacity of olive oil phenols seem to be related to their anti-inflammatory effects, 335 
which have been reported in different animal models
38, 39
. Gong, Geng, Jiang, Cao, 336 
Yoshimura&Zhong
40
 showed the capacity of HT to decrease the pro-inflammatory cytokines 337 
IL-1β and TNFα but not to increase the anti-inflammatory cytokine IL-10 in carrageenan-338 
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induced acute inflammation and hyperalgesia in rats. Moreover, the role of olive oil phenols 339 
reducing postprandial inflammatory response in obese subjects has been recently attributed to 340 
the inhibition of NF-κB, which is an important link between oxidation and inflammation in 341 
the postprandial state
41
. In the present study, diets supplemented with HT, HT-Ac and HT-Et 342 
had anti-inflammatory effects decreasing plasma TNFα in rats fed cholesterol-rich diet. 343 
Similar behaviour was observed with IL-1β although not reaching statistical significance 344 
probably due to the high variability that this parameter presented in the Chol group. In 345 
adipose tissue, supplementation with HT-Ac and HT-Et decreased MCP-1 and IL-1β below 346 
control levels.  347 
Nutrients’ mechanisms of action are strongly related with the capacity to modulate 348 
gene expression. Llorente-Cortes and co-workers
34 
showed that consuming a traditional 349 
Mediterranean diet enriched with virgin olive oil for three months improved lipid profile and 350 
plasma glucose levels, prevented the increased expression of cyclooxigenase-2 (COX2) and 351 
LDL receptor-related protein-1 (LRP-1) genes, and reduced the expression of MCP1 gene 352 
compared with a traditional Mediterranean diet enriched with nuts or with a low fat diet. 353 
COX2 and MCP1 genes are involved in inflammation whereas LRP1 takes part in foam cell 354 
formation. Likewise, Konstantinidou and co-workers
31
 observed lower plasma oxidative and 355 
inflammatory status in healthy subjects after consuming for three months a Mediterranean 356 
diet supplemented with virgin olive oil rich in phenolic compounds compared to the control 357 
group. In the study, pro-atherogenic genes related with inflammation (IFNγ, ARHGAP15 and 358 
IL7R) and oxidative stress (ADRB2) were down-regulated in peripheral blood mononuclear 359 
cells (PBMCs). Changes in gene expression were associated with decreases in lipid oxidative 360 
damage and systemic inflammation markers. In vitro studies have established the capacity of 361 
HT to modulate adipocyte lipid content and gene expression partially mediated by the 362 
reduction of the transcription factors PPARα and C/EBPα
42
. In phytochemicals’ capacity to 363 
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modify gene expression in different tissues and cell lines, the chemical structure of the 364 
phytochemical plays an important role not only in their direct scavenging of free radicals, but 365 
also in the target protein and therefore in the molecular mechanism involved in its biological 366 
action. Thus, considering the extensive hydrolysis that HT-Ac undergoes during intestinal 367 
absorption yielding HT 
15
, both compounds could follow similar mechanisms to regulate the 368 
unbalance induced by the high-cholesterol rich diet. Our results suggest changes in the 369 
expression of redox and inflammatory related genes, based on studies recently published by 370 
other research groups; however, further work is required to elucidate the molecular 371 
mechanisms underlying the regulatory metabolic effect of HT and its derivatives.  372 
A limitation of this study is that a control group fed a standard diet supplemented 373 
with HT was not included to assess the effect of this compound within a balanced diet in 374 
healthy animals. 375 
In summary, HT and its lipophilic derivatives, HT-Ac and HT-Et, were able to 376 
reduce the metabolic unbalance induced by a high-cholesterol diet in rats, being HT-Ac, the 377 
lipophilic HT derivative naturally present in virgin olive oil, the most effective phenolic 378 
compound. Since HT-Ac can be easily obtained from natural HT
12
, this compound might be 379 
proposed as an interesting bioactive ingredient in the production of functional foods, having 380 
the added value of contributing to induce beneficial metabolic properties.  381 
382 
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List of abbreviations: C group: Control group ; Chol group: cholesterol-rich diet group; 383 
AAPH: 2,2’-azobis (2-amidinopropane) dihydrochloride; COX 2: cyclooxigenase-2; FFA: 384 
Free fatty acids; HT: hydroxytyrosol; HT-Ac: hydroxytyrosyl acetate; HT-Et: ethyl 385 
hydroxytyrosyl ether; IL-1b: interleukin-1β; IL-6: interleukin-6; LRP1: LDL receptor-386 
related protein-1; MCP-1: monocyte chemoattractant protein-1; ORAC: oxygen radical 387 
scavenging capacity; PAI-1: plasminogen activator inhibitor-1; SD: standard deviation; 388 
TNF-α: tumour necrosis factor-α ; Trolox: 6-hydroxy-2,5,7,8-tetramethylchroman-2-389 
carboxilic acid 390 
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 509 
Figure Legends 510 
 511 
Figure 1. Plasma lipid profile (total-cholesterol, LDL- and HDL-Chol) of rats fed for 8 512 
weeks with standard diet (C group), cholesterol-rich diet (Chol group) and cholesterol-rich 513 
diet supplemented with hydroxytyrosol (HT group), hydroxytyrosyl acetate (HT-Ac) and 514 
ethyl hydroxytyrosyl ether (HT-Et). Data represent the means of 8 determination ± SD. Bars 515 
without a common letter differ, p< 0.05.  516 
 517 
 518 
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Figure 1.  
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Table 1. Dietary composition of the experimental diets. 
 
 
Component (g/100g dry weight) C Chol HT HT-Ac HT-Et 
Carbohydrates 65.93 64.20 64.17 64.17 64.17 
Protein 17.58 17.12 17.11 17.11 17.11 
Lipids (others than cholesterol) 3.30 3.21 3.21 3.21 3.21 
Cholesterol 0.00 2.19 2.19 2.19 2.19 
Cholic acid 0.00 0.44 0.44 0.44 0.44 
HT and derivatives 0.00 0.00 0.04 0.04 0.04 
Caloric content (Kcal/100g) 219.2 227.7 227.7 227.7 227.7 
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Table 2. Body and tissue weights of rats in the control group (C), the group consuming the non-supplemented cholesterol-rich diet (Chol) or the 1 
cholesterol-rich diet supplemented with hydroxytyrosol (HT), hydroxytyrosyl acetate (HT-Ac) and ethyl hydroxytyrosyl ether (HT-Et). Data 2 
represents the mean of 8 determinations ± SD*.  3 
 * Mean values in a row with unlike superscripts are significantly different according to Kruskal-Wallis one-way analysis of variance and Mann-Whitney 4 
U test (p< 0.05). 5 
 6 
 7 
 Standard diet Hypercholesterolemic diet 
 C Chol HT HT-Ac HT-Et 
Body weight (g)      
Inicial  242 + 6 244 + 8 244 + 7 239 + 11 243 + 4 
Final 336 + 18 326 + 30 331 + 16 317 + 10 329 + 14 
Body weight gain (g/56d) 94 + 15 82 + 32 87 + 12 78 + 11 86 + 12 
Tissue weights (g)      
Epididymal fat/ body weight 0.016 + 0.003 0.016 + 0.002 0.015 + 0.001 0.017 + 0.003 0.015 + 0.004 
Retroperitoneal fat/ body weight 0.018 + 0.004 0.015 + 0.002 0.014 + 0.002 0.017 + 0.001 0.016 + 0.005 
Ratio Retroperitoneal/epididymal 0.88 + 0.09
 a
 1.07 + 0.08
 b
 1.07 + 0.08
b
 1.00 + 0.05
ab
 0.93 + 0.07
 ab
 
Liver / body weight 0.024+ 0.002a 0.038 + 0.003b 0.029 + 0.018ab 0.036 + 0.002b 0.037 + 0.002b 
Kidney / body weight 0.0053 + 0.0022 0.0057+ 0.0005 0.0058+ 0.0008 0.0061+ 0.0005 0.0059 + 0.0006 
Heart / body weight 0.0026 + 0.0003 0.0028 + 0.0005 0.0025 + 0.0001 0.0029 + 0.0005 0.0028 + 0.0003 
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Table 3. Metabolic biomarkers in plasma and adipose tissue of rats in the control group (C), the group consuming the un-supplemented 8 
cholesterol-rich diet (Chol) or the group fed the cholesterol-rich diet supplemented with hydroxytyrosol (HT), hydroxytyrosyl acetate (HT-Ac) 9 
and ethyl hydroxytyrosyl ether (HT-Et). Data represents the means of eight determinations ± SD*.  10 
 11 
   Standard diet Hypercholesterolemic diet 
Plasma nutrients C Chol HT HT-Ac HT-Et 
 Glucose (mg/dL) 140.50 ± 15.23
a
 182.29 ± 18.17
b
 143.25 ± 19.83
a
 154.75 ± 23.36
a
 160.00 ± 22.53
ab
 
 Triglycerides (mg/dL) 106.71 ± 21.69 100.29 ± 18.33 83.00 ± 29.50 90.50 ± 19.49 84.57 ± 13.90 
 Free Fatty Acids (mM 
equivalents palmitic acid) 
0.33 ± 0.07 0.30 ± 0.13 0.34 ± 0.07 0.31 ± 0.08 0.36 ± 0.07 
 Creatinine (mg/dL) 0.52 ± 0.02
 a
 0.58 ± 0.05
 b
 0.55 ± 0.02
 b
 0.53 ± 0.03
 a
 0.53 ± 0.03
 a
 
Hormones      
 
Plasma 
Insulin (ng/mL) 972 ± 341
a
 1560.2 ± 997.9
 b
 934.1 ± 390
 a
 608.1 ± 301.6
 a
 1121.3 ± 617.1
 ab
 
 Leptin (ng/mL) 2786 ± 908
 a
 4174± 1116
 b
 3609 ± 1022
 ab
 2970 ± 1150
 a
 3468.1 ± 1291
 ab
 
 
Adipose 
tissue 
Leptin (ng/µg pr) 682 ± 189 501 ± 178 503 ± 137 503 ± 148 671 ± 283 
 Adiponectin(ng/µg 
pr) 
726415 ± 139506 658737 ± 145887 593934 ± 67860 693282 ± 139463 653668 ± 66473 
 12 
* Mean values in a row with unlike superscripts are significantly different according to Kruskal-Wallis one-way analysis of variance and Mann-Whitney 13 
U test (p< 0.05). 14 
 15 
 16 
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Table 4. Redox status and inflammatory biomarkers in plasma and adipose tissue of rats fed the control diet (C), the un-supplemented 17 
cholesterol-rich diet (Chol) and the cholesterol-rich diet supplemented with hydroxytyrosol (HT), hydroxytyrosyl acetate (HT-Ac) and ethyl 18 
hydroxytyrosyl ether (HT-Et). Data represents the mean of 8 determinations ± SD*. 19 
 20 
   Standard diet Hypercholesterolemic diet 
 C Chol HT HT-Ac HT-Et 
Antioxidant 
capacity 
Serum ORAC 
(mM T.eq) 
27.4 ± 1.8ab 25.6 ± 2.3a 28.4 ± 1.6b 28.0 ± 1.2b 26.2 ± 1.1a 
Lipid 
oxidation 
Serum (nmol/mL) 1.97 ± 0.75
a
 3.54 ± 0.24
b
 2.36 ± 0.23
a
 2.19 ± 0.39
a
 2.36 ± 0.30
a
 
Liver (nmol/mg pr) 0.98 ± 0.33
a
 3.33 ± 1.14
b
 2.52 ± 0.92
bc
 2.35 ± 0.81
bc
 2.11 ± 0.53
c
 
Inflammatory 
mediators 
Plasma 
TNFα (ng/mL) 3.0 ± 0.7
 a
 4.2 ± 0.7
 b
 3.7 ± 0.8
 a
 2.7 ± 0.6
 a
 3.4 ± 0.7
 ab
 
IL-1β (ng/mL) 11.6 ± 6.3 26.50 ± 21.5 13.8 ± 14.6 11.5 ± 7.1 8.0 ± 4.9 
IL-6 (ng/mL) 4.9 ± 4.4 3.66 ± 1.63 6.0 ± 3.3 5.7 ± 3.7 5.9 ± 2.4 
Adipose 
tissue 
TNFα (ng/µg pr) 2.5 ± 0.6 2.2 ± 0.5 2.2 ± 0.5 2.0 ± 0.4 1.9 ± 0.3 
IL-1β (ng/µg pr) 3.9 ± 0.9
 a
 3.7 ± 0.8
 a
 3.8 ± 0.6
 a
 2.9 ± 0.4
 b
 3.1 ± 0.2
 b
 
IL-6 (ng/µg pr) 24.6 ± 7.0 23.7 ± 6.1 25.7 ± 7.4 20 ± 8 23.4 ± 6.5 
MCP-1 (ng/µg pr) 32.3 ± 7.4
a
 27.6 ± 3.9
 a
 28.5 ± 3.9
 a
 26 ± 4
 b
 25.6± 3.4
 b
 
PAI-1(ng/µg pr) 87.6 ± 22.9 98.9 ± 32.9 92.4 ± 15.4 73.3 ± 18.0 81.5 ± 12.4 
 21 
* Mean values in a row with unlike superscripts are significantly different according to Kruskal-Wallis one-way analysis of variance and Mann-Whitney 22 
U test (p< 0.05).  23 
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